Page last updated: 2024-11-08

angiotensin pentapeptide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID171168
MeSH IDM0079369

Synonyms (24)

Synonym
angiotensin pentapeptide
(2s)-2-[[(2s)-1-[(2s)-2-[[(2s,3s)-2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic acid
52530-60-6
angiotensin ii (4-8)
angiotensin iii, des-(arginyl(2)-valine(3))-
angiotensin ii, des-(aspartyl(1)-arginyl(2)-valine(3))-
des-(asp(1)-arg(2)-val(3))-angiotensin ii
(des-1,2,3)angiotensin ii
angiotensin ii (4-8) pentapeptide
de-(1-asp-2-arg-3-val)-angiotensin ii
l-phenylalanine, n-(1-(n-(n-l-tyrosyl-l-isoleucyl)-l-histidyl)-l-prolyl)-
ang(4-8)
bdbm85551
DTXSID20200520
tyrosylisoleucylhistidylprolylphenylalanine
angiotensin i/ii (4-8)
angiotensin ii (4-8), human
tyr-ile-his-pro-phe
(s)-2-((s)-1-((s)-2-((2s,3s)-2-((s)-2-amino-3-(4-hydroxyphenyl)propanamido)-3-methylpentanamido)-3-(1h-imidazol-4-yl)propanoyl)pyrrolidine-2-carboxamido)-3-phenylpropanoic acid
l-tyrosyl-l-isoleucyl-l-histidyl-l-prolyl-l-phenylalanine
n,o-diethyl-n-(3-phenyl-3-(pyridin-2-yl)propyl)hydroxylamine
angiotensin i/ii(4-8)
CS-0137154
HY-P2643
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (50.00)18.7374
1990's3 (37.50)18.2507
2000's0 (0.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.97 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.27 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]